Relation between physical activity and oxygen uptake efficiency in men with CVD by McCormack, Ciara et al.
• RT & LT Far wall
Relation between Physical Activity and 
Oxygen Uptake Efficiency in Men with CVD
Presented at the European College of Sport Science Conference, Dublin, Ireland. July 2018
Results
Results
Physical activity (PA), defined as level of activity above seated rest that results
from skeletal muscle activation and leads to movement and an increase in energy
expenditure is inversely associated with reduced morbidity and mortality from
several chronic non-communicable diseases including cardiovascular disease
(CVD). Cardiorespiratory fitness is an objective measure of habitual PA. Although
VO2peak is considered the gold standard measure of CRF it is not often attained
in individuals with CVD undergoing CPET. A number of submaximal CRF indices
may improve independent of changes in VO2peak and are also used to assess
functional capacity and may be related to PA.
OUES is an effort independent submaximal CRF parameter that is derived from
the linear relation of V̇O2 (y-axis) versus the logarithm of V̇E (x-axis) during
incremental exercise (Fig 1.). Given the tight linear relation the OUES creates
between V ̇E and V̇O2max throughout a progressive CPET, this calculation has
been advanced as a measurement that requires only submaximal effort. A higher
OUES slope is indicative of a higher function capacity. It is relatively independent
of patient-achieved effort levels and reflects the absolute rate of increase in V̇O2
per 10-fold increase in ventilation and thereby reflects the integrated function and
health of the pulmonary, cardiovascular and skeletal muscle systems.
The purpose of this study was to determine the relation between light (LIPA),
moderate (MIPA) and vigorous (VIPA) intensity PA and maximal and submaximal
OUES in men with CVD.
Men (n=56) with documented CVD were recruited during an induction to a
community based exercise referral program after completion of phase 2
(hospital based) CR program. Physiological and physical characteristics and
cardiovascular events and medications are summarized in the table.
Purpose: The oxygen uptake efficiency slope (OUES) represents the rate of increase in VȮ2 in response to a given V̇E during incremental exercise, indicating how effectively
oxygen is taken in by the lungs, transported and used in the periphery. OUES, calculated using only submaximal exercise data is identical to the OUES calculated over the entire
duration of a cardiopulmonary exercise test (CEPT) , and both maximal and submaximal OUE are significantly related to cardiorespiratory fitness (CRF) measured as VȮ2peak.
Currently, little research has been published on how physical activity (PA) assessed by accelerometers is related to submaximal and maximal OUES. The purpose of this study
was to determine the relation light (LIPA), moderate (MIPA) and vigorous (VIPA) intensity physical activity and maximal and submaximal OUES in men with cardiovascular
disease (CVD).
Methods: A total of 56 men (mean ( SD): age of 59.3 ± 9.2 yr., V̇O2 peak (L/min) 2.0  0.50, V̇O2 peak (mL/kg/min) 23.6  5.8, were recruited during an induction to a
community-based exercise referral program following completion of phase 2 cardiac rehabilitation program. Participants underwent a graded exercise test on a cycle ergometer
with breath by breath open circuit spirometry after which they wore a wrist worn accelerometer (Actigraph) for 7 d. Absolute and relative submaximal and maximal OUES were
calculated by plotting V̇O2 in mL/min on the x axis, and the log transformed VE on the y axis (V̇O2 = a log 10 VE + b). Exercise data up to the ventilatory anaerobic threshold and
maximal exercise were used to calculate submaximal and maximal OUE, respectively.
Results: Participants performed 584.49  73.87 min of daily LIPA, 145.45  60.85 min of MIPA and no daily min of VIPA. There was a significant relation between absolute
submaximal OUES (r=0.386; p<0.01), submaximal OUES/Kg (r=0.296; p<0.05) and LIPA. There was a significant relation between maximal OUES (r=0.286; p<0.05), maximal
OUES/Kg (r=0.279; p<0.05) and MIPA.
Conclusion: Submaximal and maximal OUE are related to levels of LIPA and MIPA, respectively. Submaximal OUES can potentially be used as an objective, effort independent
test to estimate LIPA levels among men with CVD.
• LIPA accounted for 78% of PA undertaken during waking hours.
• No VIPA was undertaken during the 7 d period.
• There was a significant relation between LIPA and both absolute submaximal
OUES (r = 0.386; p<0.01) and submaximal OUES indexed to body weight
(OUES/kg) (r=0.296; p<0.05).
• There was a significant relation between MIPA and both maximal OUES (r = 0.286;
p<0.05), maximal OUES indexed to body weight (OUES/kg) (r=0.279; p<0.05).
• No significant relation between VȮ2 peak and either LIPA or MIPA.
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Table. Physiological and physical characteristics, cardiovascular events 
and medications
Variable Values
Age (y) 59.3  9.2
̇VO2 peak (L
.min-1) 2.00  0.50
V̇O2 peak (mL
.kg-1.min-1) 23.60  5.80
VE (L.min-1) 65.68 ± 21.56
Peak workrate (watts) 135.71 ± 40.49
Peak heart rate (b.min-1) 134.21 ± 19.58
BMI (kg.m2) 28.95 ± 3.73
Waist:Hip 0.97 ± 0 .040
Systolic blood pressure (mm Hg) 136.90 ± 17.32
Diastolic blood pressure (mm Hg) 84.58 ± 9.99
Resting heart rate (b.min-1) 67.24  ± 10.36
Cardiovascular Event
MI 24 (42)
STEMI 14 (25)
NSTEMI 10 (17)
PCI 48 (85)
CABG 7 (12)
Medications
Statins 52 (92)
Anti-platelets 49 (87)
Beta blockers 42 (75)
ACE inhibitors 25 (44)
ARB’s 8 (14)
Values are mean  SD and total number (percentage)
Participants
• Participants made a single visit to Dublin City University.
• Height, weight, hip and waist circumference were measured and participants
performed a maximal cardiopulmonary exercise test (CPET) with a 12-lead ECG.
• Breath-by-breath gas collected during the CPET was averaged at 20 s intervals.
• OUES was calculated using the equation; VO2 = a logVE + b where the constant ‘a’
represents OUES, ‘logVE’ represents the logarithm of VE and the constant ‘b’
represents the intercept (Figure 1).
• The ventilatory breakpoint method was used to determine VAT (Figure 2).
• Exercise data up to the ventilatory anaerobic threshold (Figure 2) and V̇O2 peak
were used to calculate submaximal and max OUES, respectively.
• Participants wore an accelerometer (Actigraph) continuously for 7 d and PA was
classified as LIPA, MIPA and VIPA according to Freedson et al., (1998).
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Men with documented CVD accumulate their daily min of PA by undertaking primarily
repeated bouts of LIPA. No VIPA was undertaken during the 7 d period. The findings
indicate that measures of maximal/peak metabolic rate may lack external validity with
the regard to the daily challenges faced by the O2 transport and utilization pathways in
men with CVD and a low functional capacity. The findings from the study present study
indicate that submaximal OUES and OUES/kg are significantly related to LIPA and
may be used as an objective, effort independent test to assess changes in LIPA
levels among men with CVD.
Conclusion
Figure 1. Max and submax OUES calculation Figure 2. Calculation of VAT
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